Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Metadata
Title
AMP-Activated Protein Kinase: A Master Switch in Glucose and Lipid Metabolism
Author
D. Grahame Hardie
Publication date
01-05-2004
Publisher
Kluwer Academic Publishers
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2004
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1023/B:REMD.0000021433.63915.bb

Other articles of this Issue 2/2004

Reviews in Endocrine and Metabolic Disorders 2/2004 Go to the issue

OriginalPaper

The Role of Lipid Accumulation in Liver and Muscle for Insulin Resistance and Type 2 Diabetes Mellitus in Humans

OriginalPaper

Candidate Genes for Type 2 Diabetes

OriginalPaper

Alterations of Glucose Metabolism in Type 2 Diabetes Mellitus. An Overview

OriginalPaper

Molecular Defects in Insulin Secretion in Type-2 Diabetes

OriginalPaper

New Insights into the Integrated Physiology of Insulin Action

OriginalPaper

The Role of the Liver in Type 2 Diabetes

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits